Indegene Limited (BOM:544172)
India · Delayed Price · Currency is INR 606.05
+9.70 (1.63%)
At close: Oct 7, 2026
Indegene Market Cap
Indegene has a market cap or net worth of 146.25 billion as of October 7, 2026. Its market cap has increased by 6.55% in one year.
Market Cap
146.25B
Enterprise Value
133.02B
Revenue
38.13B
Ranking
n/a
PE Ratio
36.48
Stock Price
606.05
ChartMarket Cap Chart
Since May 9, 2024, Indegene's market cap has increased from 108.15B to 146.25B, an increase of 35.23%. That is a compound annual growth rate of 13.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 146.25B | 17.08% |
| Dec 31, 2025 | 124.91B | -13.52% |
| Dec 31, 2024 | 144.45B | 33.56% |
| May 9, 2024 | 108.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.27T |
| Divi's Laboratories | 2.44T |
| Lenskart Solutions | 1.20T |
| Apollo Hospitals Enterprise | 1.15T |
| Dr. Agarwal's Health Care | 153.50B |
| NATCO Pharma | 147.14B |
| Marksans Pharma | 147.01B |
| Vijaya Diagnostic Centre | 146.34B |